Eve review
One flat $195/mo plan covers compounded semaglutide, compounded tirzepatide, or a needle-free sublingual option — plus real brand-name access if you want an FDA-approved pen instead — with a women's-health-first framing and a $99 first month, though it won't name your state until you're inside the signup flow.
then $195/mo ongoing
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Eve at a glance
- Semaglutide
- $195/mo
- Tirzepatide
- $195/mo
- Coverage
- Multiple states (not fully enumerated — confirm yours before signing up)
- Start
- After provider review (timeline not disclosed)
How we scored Eve
Each factor is scored from Eve's real pricing, disclosures and intake flow, then combined into the 69/100 Rx-Readiness Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
The pricing page says 'You pay $0 unless approved by a licensed physician,' but no review turnaround or shipping timeline is published anywhere.
Genuinely one flat $195/mo across both molecules and the sublingual form — one of the simplest pricing structures we've checked.
Nothing on the site states whether the physician review requires a live video call or is fully async — scored on the non-disclosure, not on a visit we found.
States are not enumerated; the only coverage promise is that your plan 'follows you' if you move to a state Eve already serves, which tells you nothing about your own state today.
Semaglutide and tirzepatide are both available under the same $195/mo plan, plus a sublingual option and real brand-name access.
Described as a subscription you can cancel any time; no lock-in period or cancellation fee found on the public site.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- www.tryeve.co
Re-verified live 2026-08-05: site title, promo code (semfirst99 → $99), and FDA disclaimer text all match the prior record exactly, no drift. The static site only exposes the $0/$99 promo fragment; full standing pricing sits behind the go.tryeve.co signup SPA. LegitScript ID 42862417 confirmed present in the footer. States served are not enumerated — the only coverage language is that the plan 'follows you if you relocate to a state we currently serve.' Not disclosed: named pharmacy partner, 503A/503B designation, medical director, corporate entity, governing law.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $99 → $195 | All doses (flat)Promo code semfirst99 brings the first month to $99; the standing price is $195/mo flat regardless of dose. One plan covers either molecule. |
| Compounded tirzepatide | $99 → $195 | All doses (flat)Same $195/mo flat plan and $99 first-month promo as semaglutide — Eve prices its compounded GLP-1 therapy per plan, not per molecule. |
| Oral semaglutide | $99 → $195 | SublingualA needle-free sublingual/oral form of compounded semaglutide at the same flat $195/mo. |
| Brand semaglutide | $1399 | Ozempic® |
| Brand semaglutide | $1699 | Wegovy® |
| Brand tirzepatide | $1399 | Mounjaro® |
Swipe the table to see plan details →
HSA/FSA is commonly accepted for GLP-1 telehealth — check your plan. Prices reflect Eve's public disclosures at last review and change often; confirm the current number on Eve's own site.
What we like
- One flat $195/mo price whether you pick semaglutide, tirzepatide, or the sublingual/oral form — no separate pricing tier to compare
- You aren't charged unless a licensed physician actually approves you, stated plainly on the pricing page
- Free shipping on orders over $50, and a LegitScript seal (ID 42862417) you can verify independently
- Real FDA-approved brand access (Ozempic, Wegovy, Mounjaro) on the same site if you decide compounded isn't for you
- Explicitly built around women's health, a rarer positioning than the generic weight-loss funnels most competitors run
The caveats
- Full standing pricing is gated behind the go.tryeve.co signup flow — the public site only shows the $0/$99 promo fragment, not the $195/mo rate, up front
- States served aren't enumerated anywhere; confirm yours before you start
- Named pharmacy partner, 503A/503B designation, and medical director are not disclosed
- Brand-name Ozempic/Wegovy/Mounjaro run $1,399–$1,699/mo if you want an FDA-approved product instead of the compounded plan
Eve for working moms: our verdict
One flat $195/mo plan covers compounded semaglutide, compounded tirzepatide, or a needle-free sublingual option — plus real brand-name access if you want an FDA-approved pen instead — with a women's-health-first framing and a $99 first month, though it won't name your state until you're inside the signup flow. The advertised entry is $99, but the standing rate settles near $195/month — so read the headline as a starting offer, not the monthly line on your budget.
We weigh Eve the way working moms actually have to: not just the monthly line on your budget, but how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does — the parts a generic weight-loss review skips.
What Eve actually costs
- Compounded semaglutide — All doses (flat): $99 to start, then $195/mo
- Compounded tirzepatide — All doses (flat): $99 to start, then $195/mo
- Oral semaglutide — Sublingual: $99 to start, then $195/mo
- Brand-name semaglutide — Ozempic®: $1399/mo
- Brand-name semaglutide — Wegovy®: $1699/mo
- Brand-name tirzepatide — Mounjaro®: $1399/mo
That's roughly in line with the ~$175/month median across our roster.
The medications Eve prescribes
Eve prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss outcomes, and having both on one account matters because you can switch between them without re-enrolling or hunting for a new provider mid-plan. It can route you to FDA-approved brand pens as well as compounded versions — the on-label products carry the manufacturer's own labeling, though the brand price runs well above the compounded tiers.
A needle-free oral or sublingual option is on the menu, which draws in working moms who've been avoiding injections — just set expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used.
Where Eve fits — and where it doesn't — for working moms
A good fit if…
- you want a flat price that doesn't climb every time you titrate up a dose.
Look elsewhere if…
- you'd rather the most predictable place to start and pause — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and the fine print
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing working moms can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
A standing caveat for working moms: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
Eve is a reasonable option — weigh it on how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does against the alternatives below. For most working moms, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for working moms
Best for: Working moms who want one flat price no matter which molecule or delivery form they pick, and who are comfortable confirming state coverage during signup rather than before.
Alternatives to Eve
Providers we have a referral relationship with, ordered by Rx-Readiness Score — highest first. A fee never moves a score, but it does decide who appears here, so this is not the full list: see the complete ranking.
- Visit CoreAge RxRx-Readiness95100CoreAge RxOur #1 pick
The shortlist pick: one flat price that doesn't climb as your dose does, both molecules on a single plan, and a nationwide async intake you can finish on a break.
- Visit Trimi HealthRx-Readiness88100
The price-first partner: some of the lowest flat, all-inclusive compounded pricing we track, nationwide and async — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.
- Visit Telos RxRx-Readiness86100
A fast, fully async start with a needle-free sublingual tirzepatide option and — a genuine upgrade since our last check — flat pricing stated in writing. The catch is a state list it still won't publish.
Keep comparing Eve
Head-to-head & alternatives
Eve, answered
- Does Eve's price change depending on which GLP-1 I pick?
- No — it's one flat $195/mo whether you choose compounded semaglutide, compounded tirzepatide, or the needle-free sublingual option. That's unusually simple in a category where most competitors price each molecule separately or scale with dose.
- What states does Eve serve?
- It doesn't say, at least not on the public site. The only coverage language is that your plan 'follows you if you relocate to a state we currently serve' — which tells you coverage exists somewhere, not where. Confirm your own state during signup before you count on it.
- Is the $99 price the real one?
- No — $99 is the first-month promo (code semfirst99). The standing, ongoing price is $195/mo flat. Budget for $195, not $99, when you think about month two onward.
Pricing, states and verification reflect Eve's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.